Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.580
-0.130-2.28%
Volume:35.27M
Turnover:195.82M
Market Cap:104.25B
PE:36.74
High:5.630
Open:5.605
Low:5.440
Close:5.710
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.58
T/O Rate:0.19%
Dividend:0.12
Dividend Rate:2.15%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.74
PE(LYR):36.74
PS:2.64

Loading ...

Sino Biopharmaceutical - Im-101 Injection Receives Nmpa Clinical Trial Approval for Chronic Hepatitis B

THOMSON REUTERS
·
Jul 23

Sino Biopharmaceutical Stock Slips 3.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 23

Movement Alert|SBP GROUP Declines 3.18% in Regular Trading, Trading at 5.18 HKD

Market Focus
·
Jul 23

Movement Alert|Sino Biopharmaceutical Rises 3.13% in Regular Trading, Pharma Sector Rebounds as Multiple Recent Catalysts Continue to Ferment

Market Focus
·
Jul 22

Sino Biopharmaceutical Stock Falls 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 21

Movement Alert|Sino Biopharmaceutical Falls 3.09% in Regular Trading, Trading at 5.01 HKD

Market Focus
·
Jul 21

Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong

Dow Jones
·
Jul 20

Movement Alert|Sino Biopharmaceutical Rises 3.01% in Regular Trading, Pharmaceutical Sector Rebounds Amid Multiple Pipeline Catalysts

Market Focus
·
Jul 20

Sino Biopharmaceutical Stock Slips 5.3% in Hong Kong

Dow Jones
·
Jul 17

Movement Alert|Sino Biopharmaceutical Falls 3.04% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure

Market Focus
·
Jul 17

Stock Track | Sino Biopharmaceutical Soars 5.09% Intraday on TRD205 Breakthrough Therapy Designation and Morgan Stanley Earnings Upgrade

Stock Track
·
Jul 15

Movement Alert|Sino Biopharmaceutical Rises 3.72% in Regular Trading, TRD205 Granted Breakthrough Therapy Designation Plus Morgan Stanley Raises Earnings Estimates

Market Focus
·
Jul 15

Sino Biopharmaceutical Says Trd205 Granted Breakthrough Therapy Designation by China's

Reuters
·
Jul 14

Sino Biopharma Unit Gets Breakthrough Therapy Designation for Neuropathic Pain Drug in China

MT Newswires Live
·
Jul 14

SBP GROUP's TRD205 AT2R Antagonist Receives Breakthrough Therapy Designation from CDE

Stock News
·
Jul 14

Sino Biopharmaceutical - Trd205 Granted Breakthrough Therapy Designation by China's Cde After Phase Ii Trial for Cpsnp

THOMSON REUTERS
·
Jul 14

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 14

Morgan Stanley Adjusts Earnings Per Share Forecasts for SBP GROUP Through 2028, Reiterates 'Overweight' Rating

Stock News
·
Jul 14

Sino Biopharm Files HKEX Next-day Return Disclosing Share Buyback Cancellation at HKD 4.46 Each

Reuters
·
Jul 13

SBP Group receives CDE acceptance for TQB3454 NDA targeting IDH1-mutant biliary tract cancer

Bulletin Express
·
Jul 10